TrialCancer prevention research (Philadelphia, Pa.)2020

Risk of Prostate Cancer-related Death Following a Low PSA Level in the PLCO Trial.

Rebecca Landy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.